Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
18.40
-0.08 (-0.43%)
At close: Jun 26, 2026, 4:00 PM EDT
18.00
-0.40 (-2.17%)
After-hours: Jun 26, 2026, 6:26 PM EDT
Cullinan Therapeutics Employees
Cullinan Therapeutics had 109 employees as of December 31, 2025. The number of employees decreased by 2 or -1.80% compared to the previous year.
Employees
109
Change (1Y)
-2
Growth (1Y)
-1.80%
Revenue / Employee
n/a
Profits / Employee
-$2,027,881
Market Cap
1.13B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| MannKind | 592 |
| MeiraGTx Holdings | 409 |
| Wave Life Sciences | 317 |
| Xencor | 260 |
| EyePoint | 214 |
| Sana Biotechnology | 142 |
| Olema Pharmaceuticals | 137 |
| Alpha Tau Medical | 121 |
CGEM News
- 16 days ago - Cullinan Therapeutics price target raised to $46 from $33 at Clear Street - TheFly
- 17 days ago - Cullinan Therapeutics Transcript: Immunology Day 2026 - Transcripts
- 17 days ago - Cullinan Therapeutics Slides: FY 2026 - Filings
- 17 days ago - Cullinan Therapeutics Press release: FY 2026 - Filings
- 17 days ago - Cullinan Therapeutics reports CLN-978, velinotamig data - TheFly
- 17 days ago - Cullinan Therapeutics Shares New Clinical Data Across Its Portfolio of T Cell Engager Programs Targeting CD19 and BCMA in Autoimmune Diseases - GlobeNewsWire
- 19 days ago - Cullinan Therapeutics presents clinical data for CLN-978 - TheFly
- 4 weeks ago - Cullinan to host Immunology Day event, announce data for CLN-978, Velinotamig - TheFly